ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,082Medicare Part D Prescriptions Filled, Including Refills

Rank: 91 out of 2035

$734K Total Retail Price of All Prescriptions

Rank: 125 out of 2035

513 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 513 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 513 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 12,520 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LEVOTHYROXINE SODIUM 693 662 1 4
SIMVASTATIN 598 585 2 1
OMEPRAZOLE 491 458 3 5
AMLODIPINE BESYLATE 488 480 4 6
LISINOPRIL 429 415 5 3
FUROSEMIDE 427 420 6 7
METOPROLOL TARTRATE 334 322 7 8
WARFARIN SODIUM 275 253 8 11
CITALOPRAM HBR 275 254 8 20
TRAZODONE HCL 270 260 10 50
HYDROCODONE-ACETAMINOPHEN 259 248 S3 11 2
METOPROLOL SUCCINATE 246 245 12 16
DONEPEZIL HCL 227 227 13 24
NAMENDA 224 224 14 37
ATORVASTATIN CALCIUM 181 173 15 13
MIRTAZAPINE 175 175 16 46
PRAVASTATIN SODIUM 169 164 17 17
SERTRALINE HCL 167 151 18 23
ATENOLOL 166 162 19 10
TRAMADOL HCL 149 141 20 19
POTASSIUM CHLORIDE 148 143 21 18
GABAPENTIN 145 143 22 14
HYDROCHLOROTHIAZIDE 144 142 23 12
PREDNISONE 136 135 24 36
LOSARTAN POTASSIUM 119 119 25 15
DIGOXIN 118 118 26 67
METFORMIN HCL 116 98 27 9
GLIPIZIDE 108 104 28 54
RANITIDINE HCL 108 108 28 28
EXELON 105 105 30 151
TAMSULOSIN HCL 103 103 31 25
ALLOPURINOL 92 92 32 34
SPIRIVA 89 72 33 44
LIDODERM 87 86 34 72
OXYBUTYNIN CHLORIDE ER 86 86 35 117
LOVASTATIN 79 76 36 33
AZITHROMYCIN 76 71 37 39
SYNTHROID 73 73 38 83
PROAIR HFA 71 60 39 31
KLOR-CON M20 71 71 39 73
CIPROFLOXACIN HCL 70 68 41 63
ZOLPIDEM TARTRATE 70 70 41 21
FLUTICASONE PROPIONATE 69 61 43 29
QUETIAPINE FUMARATE 69 68 43 70
ISOSORBIDE MONONITRATE ER 64 64 45 32
ADVAIR DISKUS 64 64 45 38
LANTUS 63 47 47 40
CARVEDILOL 62 62 48 22
DIVALPROEX SODIUM 60 60 49 75
FLUOXETINE HCL 59 59 50 81
DILTIAZEM 24HR ER 59 59 50 143
ALENDRONATE SODIUM 59 57 50 27
TRIAMTERENE-HCTZ 59 59 50 35
VENLAFAXINE HCL ER 59 56 50 130
DIOVAN 58 58 55 76
ROPINIROLE HCL 58 58 55 113
ACETAMINOPHEN-CODEINE 57 57 S3 57 52
SPIRONOLACTONE 55 45 58 65
POLYETHYLENE GLYCOL 3350 55 54 58 48
BUSPIRONE HCL 54 54 60 176
ESCITALOPRAM OXALATE 53 53 61 77
CEPHALEXIN 52 52 62 91
CARBIDOPA-LEVODOPA 50 50 63 94
AGGRENOX 50 50 63 295
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 7, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.